Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. 2011

Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. rperlis@partners.org

BACKGROUND It has been suggested that patients with major depressive disorder (MDD) who display pretreatment features suggestive of bipolar disorder or bipolar spectrum features might have poorer treatment outcomes. OBJECTIVE To assess the association between bipolar spectrum features and antidepressant treatment outcome in MDD. METHODS Open treatment followed by sequential randomized controlled trials. METHODS Primary and specialty psychiatric outpatient centers in the United States. METHODS Male and female outpatients aged 18 to 75 years with a DSM-IV diagnosis of nonpsychotic MDD who participated in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. METHODS Open treatment with citalopram followed by up to 3 sequential next-step treatments. METHODS Number of treatment levels required to reach protocol-defined remission, as well as failure to return for the postbaseline visit, loss to follow-up, and psychiatric adverse events. For this secondary analysis, putative bipolar spectrum features, including items on the mania and psychosis subscales of the Psychiatric Diagnosis Screening Questionnaire, were examined for association with treatment outcomes. RESULTS Of the 4041 subjects who entered the study, 1198 (30.0%) endorsed at least 1 item on the psychosis scale and 1524 (38.1%) described at least 1 recent maniclike/hypomaniclike symptom. Irritability and psychoticlike symptoms at entry were significantly associated with poorer outcomes across up to 4 treatment levels, as were shorter episodes and some neurovegetative symptoms of depression. However, other indicators of bipolar diathesis including recent maniclike symptoms and family history of bipolar disorder as well as summary measures of bipolar spectrum features were not associated with treatment resistance. CONCLUSIONS Self-reported psychoticlike symptoms were common in a community sample of outpatients with MDD and strongly associated with poorer outcomes. Overall, the data do not support the hypothesis that unrecognized bipolar spectrum illness contributes substantially to antidepressant treatment resistance.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
September 2014, Bipolar disorders,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
January 2003, Psychotherapy and psychosomatics,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
January 2019, The Journal of clinical psychiatry,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
March 2016, The Psychiatric clinics of North America,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
September 2010, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
May 2014, International clinical psychopharmacology,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
April 2009, Acta psychiatrica Scandinavica,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
March 2024, Chinese medical journal,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
April 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
Roy H Perlis, and Rudolf Uher, and Michael Ostacher, and Joseph F Goldberg, and Madhukar H Trivedi, and A John Rush, and Maurizio Fava
October 2013, Journal of affective disorders,
Copied contents to your clipboard!